Valiant Laborato

{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "58.99",
    "chg": 0.99,
    "chgp": "1.71%",
    "dir": 1,
    "prev_price": "58.00",
    "mcapval": "328.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0JWS01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.6 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-laborato-10039033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Valiant Laboratories Ltd Gains 1.16%: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-gains-116-4-key-factors-driving-the-week-3812360",
        "imagepath": "",
        "date": "2026-01-31 10:01:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> New 52-week low at Rs.57.8</p>\n                    <p><strong>28 Jan:</strong> Further decline to 52-week low of Rs.57.02</p>\n                    <p><strong>29 Jan:</strong> Stock hits all-time low near Rs.56.48</p>\n                    <p><strong>30 Jan:</strong> Recovery to Rs.59.18 (+2.28%) closes the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.58.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.59.18</div><div class=\"stat-change positive\">+1.16%</div>..."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs 56.48",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs-5648-3809904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3809904.png",
        "date": "2026-01-29 15:45:47",
        "description": "Valiant Laboratories Ltd has reached a new 52-week low, closing at Rs 56.48 on 29 Jan 2026, marking a significant decline amid broader market gains. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the share price now trading well below all key moving averages."
      },
      {
        "title": "Valiant Laboratories Ltd Hits All-Time Low Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-hits-all-time-low-amidst-prolonged-underperformance-3809865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3809865.png",
        "date": "2026-01-29 15:28:02",
        "description": "Shares of Valiant Laboratories Ltd have declined to an all-time low, reflecting a sustained period of underperformance relative to the broader market and sector benchmarks. The pharmaceutical and biotechnology company’s stock closed near its 52-week low, underscoring the severity of its current valuation and financial position."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.57.02",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs5702-3808007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3808007.png",
        "date": "2026-01-28 15:43:18",
        "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.57.02, marking a significant decline in its stock price amid broader market gains. This drop reflects ongoing concerns about the company’s financial health and valuation metrics despite recent sales and profit growth."
      },
      {
        "title": "Valiant Laboratories Ltd Falls to 52-Week Low of Rs.57.8",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-to-52-week-low-of-rs578-3806447",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3806447.png",
        "date": "2026-01-27 18:02:39",
        "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.57.8 today, marking a significant decline in its share price amid a challenging market environment and subdued long-term fundamentals."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3804015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_mojoScore_3804015.png",
        "date": "2026-01-25 10:10:30",
        "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 January 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Valiant Laboratories Ltd Falls 9.48% This Week: 7 Key Factors Behind the Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-948-this-week-7-key-factors-behind-the-decline-3802875",
        "imagepath": "",
        "date": "2026-01-24 10:02:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Jan:</strong> Stock hits 52-week and all-time low at Rs.63.05</p>\n                    <p><strong>20 Jan:</strong> New 52-week and all-time low at Rs.60.00 amid continued downtrend</p>\n                    <p><strong>21 Jan:</strong> Further 52-week low at Rs.58.63, closing near all-time low</p>\n                    <p><strong>22 Jan:</strong> Stock falls to fresh 52-week low of Rs.57.85</p>\n                    <p><strong>23 Jan:</strong> Week closes at Rs.58.50, down 2.50% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.64.63</div></div>\n    ..."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.57.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs5785-3800293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3800293.png",
        "date": "2026-01-22 12:44:45",
        "description": "Valiant Laboratories Ltd has reached a new 52-week low of Rs.57.85, marking a significant decline in its share price amid a challenging market environment and subdued financial metrics."
      },
      {
        "title": "Valiant Laboratories Ltd Stock Hits All-Time Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-hits-all-time-low-amidst-continued-downtrend-3798100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ValiantLaborato_priceRelatedfactors_3798100.png",
        "date": "2026-01-21 10:07:53",
        "description": "Shares of Valiant Laboratories Ltd have declined to an all-time low, reflecting a sustained period of underperformance relative to the broader market and its sector peers. The pharmaceutical and biotechnology company’s stock closed near its 52-week low, underscoring the severity of its current valuation challenges."
      }
    ],
    "total": 283,
    "sid": "10039033",
    "stock_news_url": "https://www.marketsmojo.com/news/valiant-laboratories-10039033"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "15-Jan-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate under 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "26-Dec-2025",
      "details": "Pls find enclosed",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Valiant Laboratories Ltd Gains 1.16%: 4 Key Factors Driving the Week

2026-01-31 10:01:26

Key Events This Week

27 Jan: New 52-week low at Rs.57.8

28 Jan: Further decline to 52-week low of Rs.57.02

29 Jan: Stock hits all-time low near Rs.56.48

30 Jan: Recovery to Rs.59.18 (+2.28%) closes the week

Week Open

Rs.58.50

Week Close

Rs.59.18

+1.16%

...

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs 56.48

2026-01-29 15:45:47

Valiant Laboratories Ltd has reached a new 52-week low, closing at Rs 56.48 on 29 Jan 2026, marking a significant decline amid broader market gains. The stock’s recent performance reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the share price now trading well below all key moving averages.

Read full news article

Valiant Laboratories Ltd Hits All-Time Low Amidst Prolonged Underperformance

2026-01-29 15:28:02

Shares of Valiant Laboratories Ltd have declined to an all-time low, reflecting a sustained period of underperformance relative to the broader market and sector benchmarks. The pharmaceutical and biotechnology company’s stock closed near its 52-week low, underscoring the severity of its current valuation and financial position.

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.57.02

2026-01-28 15:43:18

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.57.02, marking a significant decline in its stock price amid broader market gains. This drop reflects ongoing concerns about the company’s financial health and valuation metrics despite recent sales and profit growth.

Read full news article

Valiant Laboratories Ltd Falls to 52-Week Low of Rs.57.8

2026-01-27 18:02:39

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.57.8 today, marking a significant decline in its share price amid a challenging market environment and subdued long-term fundamentals.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-01-25 10:10:30

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 January 2026, providing investors with the latest comprehensive view of the company’s position.

Read full news article

Valiant Laboratories Ltd Falls 9.48% This Week: 7 Key Factors Behind the Decline

2026-01-24 10:02:07

Key Events This Week

19 Jan: Stock hits 52-week and all-time low at Rs.63.05

20 Jan: New 52-week and all-time low at Rs.60.00 amid continued downtrend

21 Jan: Further 52-week low at Rs.58.63, closing near all-time low

22 Jan: Stock falls to fresh 52-week low of Rs.57.85

23 Jan: Week closes at Rs.58.50, down 2.50% on the day

Week Open

Rs.64.63

...

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.57.85

2026-01-22 12:44:45

Valiant Laboratories Ltd has reached a new 52-week low of Rs.57.85, marking a significant decline in its share price amid a challenging market environment and subdued financial metrics.

Read full news article

Valiant Laboratories Ltd Stock Hits All-Time Low Amidst Continued Downtrend

2026-01-21 10:07:53

Shares of Valiant Laboratories Ltd have declined to an all-time low, reflecting a sustained period of underperformance relative to the broader market and its sector peers. The pharmaceutical and biotechnology company’s stock closed near its 52-week low, underscoring the severity of its current valuation challenges.

Read full news article

View All News